<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mem Inst Oswaldo Cruz</journal-id><journal-id journal-id-type="iso-abbrev">Mem. Inst. Oswaldo Cruz</journal-id><journal-id journal-id-type="publisher-id">mioc</journal-id><journal-title-group><journal-title>Mem&#x000f3;rias do Instituto Oswaldo Cruz</journal-title></journal-title-group><issn pub-type="ppub">0074-0276</issn><issn pub-type="epub">1678-8060</issn><publisher><publisher-name>Instituto Oswaldo Cruz, Minist&#x000e9;rio da Sa&#x000fa;de</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7427313</article-id><article-id pub-id-type="doi">10.1590/0074-02760200225</article-id><article-id pub-id-type="other">00414</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title>Low risk of serological cross-reactivity between dengue and COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5377-7118</contrib-id><name><surname>Spinicci</surname><given-names>Michele</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="c">
<sup>+</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bartoloni</surname><given-names>Alessandro</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mantella</surname><given-names>Antonia</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zammarchi</surname><given-names>Lorenzo</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rossolini</surname><given-names>Gian Maria</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Antonelli</surname><given-names>Alberto</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>University of Florence, Department of Experimental and Clinical Medicine, Florence, Italy</aff><aff id="aff2">
<label>2</label>Careggi University Hospital, Infectious and Tropical Diseases Unit, Florence, Italy</aff><aff id="aff3">
<label>3</label>Careggi University Hospital, Microbiology and Virology Unit, Florence, Italy</aff><author-notes><corresp id="c">+ Corresponding author: <email>michele.spinicci@unifi.it</email></corresp><fn fn-type="con" id="fn2"><p>MS, AB, LZ and GMR contributed to the study design; AA and AM performed laboratory tests. All authors contributed to data analysis, interpretation and critically reviewed the paper.</p></fn></author-notes><pub-date pub-type="epub"><day>14</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>115</volume><elocation-id>e200225</elocation-id><history><date date-type="received"><day>10</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>04</day><month>8</month><year>2020</year></date></history><permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p></license></permissions><abstract><p>In the near future, the overlap of Coronavirus disease 2019 (COVID-19) and dengue epidemics is a concrete threat in tropical regions. Co-epidemics of COVID-19 and dengue could be an overwhelming challenge for health systems in low- and middle-income countries. In this work, we investigated potential serological cross-reactions between COVID-19 and dengue patients. Among 32 COVID-19 positive sera, no positive Dengue virus (DENV) IgG/IgM results were observed. On the other hand, one false-positive result was observed among 44 DENV-positive sera tested for COVID-19 antibodies with each of the two rapid tests used. Further data on accuracy of COVID-19 diagnostic test are urgently warranted.</p></abstract><kwd-group><title>Key words:</title><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>dengue</kwd><kwd>antibodies</kwd></kwd-group><counts><ref-count count="12"/></counts></article-meta></front><body><p>Since December 2019, Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in the international scene as a major public health concern. COVID-19 pandemic is having a disrupting impact on health systems throughout Asia, Europe and America.<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref> At the same time, a large outbreak of dengue is ongoing in Latin American countries, with several deaths being recorded.<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
</p><p>In the near future, the overlap of COVID-19 and dengue epidemics is a concrete threat in tropical regions.<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref> COVID-19 and dengue share several features of clinical and laboratory presentation, and differential diagnosis should rely on specific diagnostic tests.<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref> Recently, two cases of false-positive results by rapid diagnostic test (RDT) for dengue in patients with SARS-CoV-2 infection were reported from Singapore.<xref rid="B6" ref-type="bibr">
<sup>6</sup>
</xref> If serological cross-reactivity between patients with COVID-19 and dengue will be confirmed, it may result in a high number of misdiagnoses, with dangerous consequences both from the patients and from public health point of view.<xref rid="B7" ref-type="bibr">
<sup>7</sup>
</xref>
</p><p>In order to further explore this possibility, we investigated potential serological cross-reactions between COVID-19 and dengue patients, by performing commercial assays for detection of anti-Dengue virus (DENV) and anti-SARS-CoV-2 antibodies on sera from well-characterised COVID-19- and dengue-positive patients, respectively.</p><p>A total of 32 anonymised sera, obtained from symptomatic patients with COVID-19 diagnosed by positive anti-SARS-CoV-2 IgM/IgG (32/32, tested by 2019-NCOV IgG/IgM Rapid Test Cassette, ScreenItalia, Perugia, Italy) and/or RT-PCR for SARS-CoV-2 on nasopharyngeal swab (26/32), were tested by Dengue Enzyme Linked Immune Assay (ELISA) DENV IgG-IgM (VIRCELL, Granada, Spain). Sera were collected and tested in Italy, at the Careggi University Hospital of Florence, where dengue is not endemic, and previous exposure to DENV was unlikely.</p><p>Moreover, 44 anonymised DENV-positive sera, from cases of acute dengue (27 of whom confirmed by NS1 antigen positivity, plus 17 probable diagnosis with only IgM and IgG positivity), were tested by using COVID-19 IgG/IgM Rapid Test Cassette (Orient Gene, Zhejiang, China) and 2019-NCOV IgG/IgM Rapid Test Cassette (ScreenItalia, Perugia, Italy). All DENV-positive sera were collected from travellers, before SARS-CoV-2 emergence.</p><p>Among 32 COVID-19 positive sera, no positive DENV IgG/IgM results were observed. On the other hand, one false-positive result was observed among 44 DENV-positive sera tested for COVID-19 antibodies with each method (in one case for IgG and IgM, and in another for IgG only), in two different samples.</p><p>Serological test for dengue are known to be affected by cross-reactivity issues in areas were multiple Flavivirus, such as Zika, Yellow fever or Japanese encephalitis virus are circulating. The risk of false-positive results is reduced when dengue IgM/IgG testing is paired with NS1 antigen capture.<xref rid="B8" ref-type="bibr">
<sup>8</sup>
</xref>
</p><p>According with our results, the concern about false-positive dengue serology in COVID-19 patients could be downsized, at least when an ELISA is used. On the other hand, COVID-19 false-positive results are possible in patients with DENV infection, although at a low rate and variably using different RDTs for COVID-19. It should be also considered that these COVID-19 false-positive results may reflect different aspecific cross-reactivity, not necessarily related to DENV-specific antibodies.<xref rid="B9" ref-type="bibr">
<sup>9</sup>
</xref> Of course, this is a preliminary study on a limited number of samples, which need to be validated on a wider population.</p><p>In low- and middle-income countries, where arboviruses and other common tropical diseases are highly endemic, SARS-CoV-2 spread will represent an additional challenge for clinicians.<xref rid="B10" ref-type="bibr">
<sup>10</sup>
</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">
<sup>11</sup>
</xref> In particular, co-epidemics of COVID-19 and dengue could be an overwhelming situation for health systems.<xref rid="B12" ref-type="bibr">
<sup>12</sup>
</xref> Further studies are warranted to better elucidate the accuracy of commercially available RDTs for SARS-CoV-2 antibodies detection and their role within the strategy for COVID-19 diagnosis and control.</p></body><back><fn-group><fn fn-type="financial-disclosure" id="fn1"><p>Financial support: This article has been supported by funds of Ministry of Education, University and Research (Italy) Excellence Departments 2018-2022 (Project for the Department of Experimental and Clinical Medicine).</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Coronavirus disease (COVID-2019) situation reports</article-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/</ext-link></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>PAHO/WHO - Pan American Health Organization/World Health Organization</collab></person-group><source>Epidemiological update: arbovirus. Washington,</source><year>2020</year><publisher-loc>DC</publisher-loc><publisher-name>PAHO/WHO</publisher-name></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>JC</given-names></name><name><surname>Arrivillaga-Henr&#x000ed;quez</surname><given-names>J</given-names></name><name><surname>Salazar-Loor</surname><given-names>J</given-names></name><name><surname>Rodriguez-Morales</surname><given-names>AJ</given-names></name></person-group><article-title>COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: pushing strained health care systems over the edge</article-title><source>Travel Med Infect Dis</source><year>2020</year></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>C</given-names></name><name><surname>Azevedo</surname><given-names>TS</given-names></name><name><surname>Chiaravalloti-Neto</surname><given-names>F</given-names></name></person-group><article-title>COVID-19 and dengue fever a dangerous combination for the health system in Brazil</article-title><source>Travel Med Infect Dis</source><year>2020</year><volume>35</volume><fpage>101659</fpage><lpage>101659</lpage><pub-id pub-id-type="pmid">32278756</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>LTM</given-names></name><name><surname>Chua</surname><given-names>YX</given-names></name><name><surname>Tan</surname><given-names>DHY</given-names></name></person-group><article-title>Roles and challenges of primary care physicians facing a dual outbreak of COVID-19 and dengue in Singapore</article-title><source>Fam Pract</source><year>2020</year></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name><name><surname>Lam</surname><given-names>LTM</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Chua</surname><given-names>YX</given-names></name><name><surname>Lim</surname><given-names>AYN</given-names></name></person-group><article-title>Covert COVID-19 and false-positive dengue serology in Singapore</article-title><source>Lancet Infect Dis</source><year>2020</year><volume>20</volume><issue>5</issue><fpage>536</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">32145189</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Pei</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name></person-group><article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)</article-title><source>Science</source><year>2020</year><volume>368</volume><issue>6490</issue><fpage>489</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">32179701</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>DA</given-names></name><name><surname>Depelsenaire</surname><given-names>AC</given-names></name><name><surname>Young</surname><given-names>PR</given-names></name></person-group><article-title>Clinical and laboratory diagnosis of dengue virus infection</article-title><source>J Infect Dis</source><year>2017</year><volume>215</volume><issue>Suppl. 2</issue></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethuraman</surname><given-names>N</given-names></name><name><surname>Jeremiah</surname><given-names>SS</given-names></name><name><surname>Ryo</surname><given-names>A</given-names></name></person-group><article-title>Interpreting diagnostic tests for SARS-CoV-2.</article-title><source>JAMA</source><year>2020</year></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bokhari</surname><given-names>SMMA</given-names></name><name><surname>Mahmood</surname><given-names>F</given-names></name><name><surname>Bokhari</surname><given-names>SMSA</given-names></name></person-group><article-title>Case report diagnosis of novel Coronavirus disease (COVID-19) versus tropical diseases in Pakistan</article-title><source>Am J Trop Med Hyg</source><year>2020</year><volume>103</volume><issue>1</issue><fpage>77</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">32372752</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joob</surname><given-names>B</given-names></name><name><surname>Wiwanitkit</surname><given-names>V</given-names></name></person-group><article-title>COVID-19 can present with a rash and be mistaken for dengue</article-title><source>J Am Acad Dermatol</source><year>2020</year><volume>82</volume><issue>5</issue><elocation-id>e177</elocation-id><pub-id pub-id-type="pmid">32213305</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>W</given-names></name></person-group><article-title>To alert co-infection of SARS-COV-2 and dengue virus in developing countries in the dengue-endemic area</article-title><source>Infect Control Hosp Epidemiol</source><year>2020</year></element-citation></ref></ref-list></back></article>